INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 410m ago
HOUSE PTR9m ago
SEC 13F9m ago
ROBINHOOD CHAIN9m ago
Corporate insider
CT

Curran Terrie

DirectorCIK 0001690298

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 2
Max Insider Score44
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
CT
Curran TerrieDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M$84K
11.1K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Arcutis Biotherapeutics, Inc.Director · Aug 28, 2026
40
CT
Curran TerrieDirector
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL
$279K
11.1K sh
Aug 27, 2026
Aug 28, 2026
traded Aug 27, 2026
+1d
SEC FORM 4

Evidence

24
CT
Curran TerrieDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M$233K
27.1K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

44
CT
Curran TerrieDirector
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$677K
27.1K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

9
CT
Curran TerrieDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M—
11.1K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence

9
CT
Curran TerrieDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M—
27.1K sh
Aug 27, 2026Aug 28, 2026
traded Aug 27, 2026
+1dSEC FORM 4

Evidence